|
Wound Care : Odor Control
Odor from malignant cutaneous wounds, ulcerated tumors, some pressure
ulcers, and fungating tumors can cause great distress and embarrassment
for patients. Topical metronidazole is one medication that has been
used to eliminate this odor, greatly improving the patient’s
quality of life. Exudate and associated cellulitis may also
decrease significantly with appropriate topical therapy.
Ostomy Wound Manage 1997 Jan-Feb;43(1):56-60, 62, 64-6
Malignant Cutaneous Wounds: a Management Protocol
Haisfield-Wolfe ME, Rund C
Johns Hopkins Oncology Center, Baltimore, MD, USA.
Malignant cutaneous wounds are emotionally traumatic and difficult
to manage lesions which occur secondary to infiltration of cancer
into the skin. They occur in patients with end-stage disease and
are highly exudative, malodorous, and bleed easily. Quality of life
is the goal for treatment, which includes radiation, chemotherapy,
surgery, and local wound care. Odor is addressed with varying levels
of success through wound cleansing, external deodorizers, charcoal-impregnated
dressings, topical antimicrobial therapy, and metronidazole. Exudate
is managed with highly absorbent dressing materials, topical steroids
or hyoscine (a drying agent). Light bleeding is controlled with local
pressure and hemostatic dressings; heavier bleeding may require ligation
or cauterization. Cosmetic appearance and other psychosocial issues
must be assessed on an ongoing basis. Creative dressing techniques
can help restore the look of symmetry to the patient's body. Effective
wound management, debridement, and antimicrobial theray can reduce
the risk of infection. Wound cleansing, through irrigation or flushing,
should not cause pain, further trauma or bleeding. Dressings should
maintain a moist wound environment and not traumatize the wound upon
removal. A protocol is included which can be individualized to the
needs of each patient and addresses assessment, interventions, patient
teaching, documentation, and expected outcomes.
PMID: 9087066 |